Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base
- 1 November 2017
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (2) , 296-301
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumorsGynecologic Oncology, 2016
- Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell TumorsInternational Journal of Gynecological Cancer, 2014
- Yolk Sac Tumor of the Ovary: A Retrospective Multicenter Study of 33 Japanese Women by Tohoku Gynecologic Cancer Unit (TGCU)The Tohoku Journal of Experimental Medicine, 2013
- Malignant ovarian germ-cell tumoursBest Practice & Research Clinical Obstetrics & Gynaecology, 2012
- Prognostic factors in women treated for ovarian yolk sac tumour: A retrospective analysis of 84 casesEuropean Journal of Cancer, 2011
- Yolk sac tumours of the ovary: Evaluation of clinicopathological features and prognostic factorsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumorAnnals of Oncology, 2008
- Yolk sac tumours of the ovary: an updateEuropean Journal of Surgical Oncology, 2006
- Endodermal sinus tumor of the ovary: The Hacettepe University experienceEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- Prognostic factors of patients with yolk sac tumors of the ovaryAmerican Journal of Obstetrics and Gynecology, 2001